Drug recall · November 1, 2017
ENALAPRIL MALEATE Tablets recall
Why: Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By: Aidarex Pharmaceuticals; NDC 33261-0693-90.
- Lots / codes
Lot #: 55097-2, 56085-1, Exp 11/30/2018
- Quantity
- 12 bottles
- Company
- Aidarex Pharmaceuticals LLC, Corona, CA
- Distribution
- Product was distributed in Florida
- Initiated
- September 5, 2017 · Voluntary: Firm initiated
- Classified
- October 26, 2017
- Reported
- November 1, 2017
- Ended
- December 1, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Enalapril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.